SGD Pharma and Corning Incorporated entities have set up a joint venture in India for a new glass tubing facility to expand pharmaceutical manufacturing in Telangana, India. Combining SGD Pharma’s vial-converting expertise with Corning’s proprietary glass-coating technology, the collaboration will enhance vial quality, improve filling-line productivity, and speed the global delivery of injectable treatments. The joint venture will help drugmakers respond to increasingly complex capacity and quality issues while meeting global demand for critical medicines.
Reference could be made to the following link for the transaction: SGD Pharma x Corning News Release_080623.pdf (sgd-pharma.com). JSA advised SGD Pharma.
Our Transaction Team Comprised Partner – Rinku Ambekar, Principal Associate – Reshma Oak.
Our Competition Team Partner – Vaibhav Choukse and Ela Bali, Senior Associate – Aditi Khanna.
Ela is a partner with JSA’s competition law practice with 10 years of experience. She represents and advises clients across different sectors on enforcement and merger control matters before the Competition Commission of India (CCI), National Company Law Appellate Tribunal (NCLAT), Delhi and Bombay High Court, and the Supreme Court of India (SC).
Rinku has a diverse corporate practice focused on cross-border M&A representing clients in the United States, Europe, Singapore, Malaysia, Japan, Australia, United Kingdom and her experience extends to takeovers, buyouts, private equity transactions, creation of joint ventures, strategic alliances, stock acquisitions, business acquisitions, asset acquisitions, restructurings, corporate governance, commercial and corporate agreements.
Vaibhav is a Partner with Firm’s Competition Law Practice with over 15 years’ experience.